» Articles » PMID: 2548761

Marked Reduction of Free Radical Generation and Contractile Dysfunction by Antioxidant Therapy Begun at the Time of Reperfusion. Evidence That Myocardial "stunning" is a Manifestation of Reperfusion Injury

Overview
Journal Circ Res
Date 1989 Sep 1
PMID 2548761
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence suggests that postischemic myocardial dysfunction ("stunning") may be mediated by oxygen free radicals, but the exact time window during which the critical radical-mediated damage develops remains unknown. Furthermore, the evidence for the oxyradical hypothesis is indirect and, therefore, inconclusive. Thus, the potent and cell-permeable antioxidant N-(2-mercaptopropionyl)-glycine (MPG) was administered as an intra-coronary infusion (8 mg/kg/hr) to three groups of open-chest dogs undergoing a 15-minute coronary occlusion followed by 4 hours of reperfusion. In group I (n = 8), the infusion of MPG was started 15 minutes before occlusion and ended 2 hours after reperfusion; in group II (n = 9), MPG was started 1 minute before reperfusion and ended 2 hours thereafter; in group III (n = 10), MPG was started 1 minute after reperfusion and ended 2 hours and 15 minutes thereafter. Control dogs (group IV) (n = 10) received vehicle. Recovery of contractile function (assessed as systolic wall thickening) was equivalent in groups I and II, and in both groups it was substantially greater than in controls (p less than 0.005 at 4 hours). In contrast, in group III recovery of function was indistinguishable from controls. To determine whether the protection afforded by MPG was due to inhibition of free radical reactions, myocardial production of free radicals was directly assessed by intracoronary infusion of the spin trap alpha-phenyl N-tert-butyl nitrone (PBN). In control dogs (group VII, n = 6), radical adducts of PBN were released in the coronary venous blood after reperfusion, with a burst occurring in the first 5 minutes. MPG given as in group II (group V, n = 5) markedly suppressed myocardial production of PBN adducts (delta = -98% over 3 hours, p less than 0.01 vs. controls); this effect was evident immediately after reperfusion. MPG given as in group III (group VI, n = 5) also suppressed PBN adduct production (delta = -83% over 3 hours, p less than 0.025 vs. controls), but this effect was delayed. Hence, the radicals important in myocardial stunning appear to be those generated immediately after reperfusion. In vitro studies demonstrated that MPG is an exceptionally powerful scavenger of .OH (rate constant = 8.1 x 10(9) M-1 sec-1 by pulse radiolysis) but has no significant effect on .O2- (rate constant less than 10(3) M-1 sec-1), H2O2 (rate constant = 1.6 M-1 sec-1), or non-.OH-initiated lipid peroxidation, suggesting that removal of .OH is the major mechanism of the beneficial effects of MPG.(ABSTRACT TRUNCATED AT 400 WORDS)

Citing Articles

Bupropion Showed Neuroprotective Impacts Against Cerebral Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation.

Baba Ahmadi S, Afrand Khalilabad Z, Alemohammad S, Yousefi Manesh H, Abdollahi A, Jazayeri F Iran J Pharm Res. 2025; 23(1):e156838.

PMID: 40066118 PMC: 11892747. DOI: 10.5812/ijpr-156838.


2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.

Wahba A, Kunst G, De Somer F, Kildahl H, Milne B, Kjellberg G Eur J Cardiothorac Surg. 2025; 67(2).

PMID: 39949326 PMC: 11826095. DOI: 10.1093/ejcts/ezae354.


2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.

Wahba A, Kunst G, De Somer F, Kildahl H, Milne B, Kjellberg G Interdiscip Cardiovasc Thorac Surg. 2025; 40(2).

PMID: 39949317 PMC: 11826094. DOI: 10.1093/icvts/ivaf002.


NADPH Oxidase 3: Beyond the Inner Ear.

Herb M Antioxidants (Basel). 2024; 13(2).

PMID: 38397817 PMC: 10886416. DOI: 10.3390/antiox13020219.


CARDIOPROTECTIVE EFFECT OF DICHLOROMETHANE VALERIAN (VALERIANA OFFICINALIS) EXTRACT ON ISCHEMIA-REPERFUSION-INDUCED CARDIAC INJURIES IN RATS.

Sedighi M, Seidi H, Asadi F, Biranvand H, Banaei P, Torkashvand M Acta Endocrinol (Buchar). 2023; 19(2):178-186.

PMID: 37908890 PMC: 10614589. DOI: 10.4183/aeb.2023.178.